The influence of tumor- and treatment-related factors on the development of local recurrence in osteosarcoma after adequate surgery. An analysis of 1355 patients treated on neoadjuvant Cooperative Osteosarcoma Study Group protocols.
Andreou
D
D
Department of Orthopedic Oncology, Sarcoma Center Berlin-Brandenburg, Helios Klinikum Berlin-Buch, Academic Teaching Hospital of the Charité Universitätsmedizin, Berlin. Electronic address: dimosthenis.andreou@helios-kliniken.de.
Bielack
S S
SS
Pediatrics 5-Oncology, Hematology and Immunology, COSS Study Center, Olgahospital, Klinikum Stuttgart, Stuttgart, Germany.
Carrle
D
D
Pediatrics 5-Oncology, Hematology and Immunology, COSS Study Center, Olgahospital, Klinikum Stuttgart, Stuttgart, Germany.
Kevric
M
M
Pediatrics 5-Oncology, Hematology and Immunology, COSS Study Center, Olgahospital, Klinikum Stuttgart, Stuttgart, Germany.
Kotz
R
R
Department of Orthopedic Surgery, University Hospital of Vienna, Vienna, Austria.
Winkelmann
W
W
Department of General Orthopedics and Tumororthopedics, University Hospital of Muenster, Muenster, Germany.
Jundt
G
G
Department of Pathology, Universitätsspital Basel, Basel, Switzerland.
Werner
M
M
Department of Pathology, Sarcoma Center Berlin-Brandenburg, Helios Klinikum Emil von Behring, Berlin, Germany.
Fehlberg
S
S
Department of Orthopedic Oncology, Sarcoma Center Berlin-Brandenburg, Helios Klinikum Berlin-Buch, Academic Teaching Hospital of the Charité Universitätsmedizin, Berlin.
Kager
L
L
Department of Hematology/Oncology, St Anna Children's Hospital, Vienna, Austria.
Kühne
T
T
Division of Oncology/Hematology, University Children's Hospital, Basel, Switzerland.
Lang
S
S
Department of Pathology, University Hospital of Vienna, Vienna, Austria.
Dominkus
M
M
Department of Orthopedic Surgery, University Hospital of Vienna, Vienna, Austria.
Exner
G U
GU
Department of Orthopedics, Balgrist University Hospital, Zurich, Switzerland.
Hardes
J
J
Department of General Orthopedics and Tumororthopedics, University Hospital of Muenster, Muenster, Germany.
Hillmann
A
A
Department of Orthopedics, Klinikum Ingolstadt, Ingolstadt.
Ewerbeck
V
V
Department of Orthopedics and Traumatology, University Hospital of Heidelberg, Heidelberg.
Heise
U
U
Department of Orthopedics, Albertinen Hospital, Hamburg.
Reichardt
P
P
Department of Hematology, Oncology and Palliative Care, Sarcoma Center Berlin-Brandenburg, Helios Klinikum Bad Saarow, Academic Teaching Hospital of the Charité Universitätsmedizin, Bad Saarow, Germany.
Tunn
P-U
PU
Department of Orthopedic Oncology, Sarcoma Center Berlin-Brandenburg, Helios Klinikum Berlin-Buch, Academic Teaching Hospital of the Charité Universitätsmedizin, Berlin.
D000293:Adolescent; D000328:Adult; D000368:Aged; D002648:Child; D002675:Child, Preschool; D018572:Disease-Free Survival; D005260:Female; D006801:Humans; D053208:Kaplan-Meier Estimate; D008297:Male; D008875:Middle Aged; D015999:Multivariate Analysis; D020360:Neoadjuvant Therapy; D009364:Neoplasm Recurrence, Local / Q000401:mortality / Q000517:prevention & control*; D012516:Osteosarcoma / Q000188:drug therapy / Q000401:mortality / Q000601:surgery*; D016016:Proportional Hazards Models; D012189:Retrospective Studies; D016896:Treatment Outcome; D055815:Young Adult